Fmr LLC Acquires 1,338 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Fmr LLC grew its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 10.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 13,581 shares of the company’s stock after purchasing an additional 1,338 shares during the period. Fmr LLC owned approximately 0.13% of iShares U.S. Pharmaceuticals ETF worth $959,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Aptus Capital Advisors LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the second quarter valued at about $12,165,000. Rockport Wealth LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the second quarter worth about $12,091,000. Kraft Davis & Associates LLC grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 30.6% during the 2nd quarter. Kraft Davis & Associates LLC now owns 31,722 shares of the company’s stock valued at $2,197,000 after purchasing an additional 7,428 shares during the last quarter. Marshall Wace LLP acquired a new position in iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth approximately $422,000. Finally, Thrivent Financial for Lutherans increased its position in iShares U.S. Pharmaceuticals ETF by 23.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock worth $2,295,000 after purchasing an additional 6,214 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $66.58 on Tuesday. The company’s 50 day moving average price is $69.24 and its two-hundred day moving average price is $69.07. The firm has a market capitalization of $672.46 million, a P/E ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $59.82 and a fifty-two week high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.